Cellular Crosstalk Between TNF-α, NADPH Oxidase, PKCβ2, and C2GNT in Human Leukocytes
Overview
Affiliations
Increasing evidence suggests that chronic, sub-clinical inflammation plays an important role in the pathogenesis of diabetic retinopathy. We have established the potential role of the inflammatory enzyme, core 2 β-1, 6-N-acetylglucosaminyltransferase (C2GNT) in diabetic retinopathy. The present study was designed to explore the NADPH oxidase signaling pathway in the tumor necrosis factor-alpha (TNF-α)-induced activity of C2GNT in leukocytes. Human leukocytes (U937 cells) and an Epstein-Barr-transformed lymphoblastoid cell line deficient in p47phox (F10007 cells) were used for the study. Cells were exposed to TNF-α for 24h in the presence and absence of 1) NADPH oxidase inhibitors (apocynin and scrambled and unscrambled gp91ds-tat), 2) LY379196 (specific protein kinase C β1/2 (PKCβ1/2) inhibitor), and 3) the antioxidant tiron. Subsequent C2GNT and NADPH activity was measured and the adhesion of U937 and F10007 cells to endothelial cells was assessed. TNF-α-induced C2GNT activity (1813±326 pmol/h/mg protein) (mean±SEM) in human leukocytes was significantly reversed with apocynin (153±82 pmol/h/mg protein), unscrambled gp91ds-tat (244±122 pmol/h/mg protein) and tiron (756±87 pmol/h/mg protein). We further supported this C2GNT-NADPH oxidase link using p47phox-deficient leukocytes. The deficiency in p47phox prevented TNF-α-induced NADPH oxidase and C2GNT activity and adherence to endothelial cells. The response to TNF-α was restored by transfection with an expression plasmid containing a p47phox cDNA inserted in the sense direction. Our results demonstrate for the first time a novel signaling crosstalk between TNF-α, NADPH oxidase, PKCβ1/2 and C2GNT in leukocytes.
Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors.
Cifuentes-Pagano M, Meijles D, Pagano P Curr Pharm Des. 2015; 21(41):6023-35.
PMID: 26510437 PMC: 4818579. DOI: 10.2174/1381612821666151029112013.
Chinese medicines induce cell death: the molecular and cellular mechanisms for cancer therapy.
Wang X, Feng Y, Wang N, Cheung F, Tan H, Zhong S Biomed Res Int. 2014; 2014:530342.
PMID: 25379508 PMC: 4212527. DOI: 10.1155/2014/530342.
Redox regulation of protein damage in plasma.
Griffiths H, Dias I, Willetts R, Devitt A Redox Biol. 2014; 2:430-5.
PMID: 24624332 PMC: 3949090. DOI: 10.1016/j.redox.2014.01.010.
NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation?.
Wieczfinska J, Sokolowska M, Pawliczak R Antioxid Redox Signal. 2014; 23(5):428-45.
PMID: 24383678 PMC: 4543397. DOI: 10.1089/ars.2013.5783.
Sharma A, Mulloy D, Le L, Laubach V Am J Physiol Lung Cell Mol Physiol. 2013; 306(1):L69-79.
PMID: 24186876 PMC: 3920214. DOI: 10.1152/ajplung.00205.2013.